ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

ClinicalTrials.gov ID: NCT03178487

Public ClinicalTrials.gov record NCT03178487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 4:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis

Study identification

NCT ID
NCT03178487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Upadacitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2017
Primary completion
Jan 20, 2019
Completion
Feb 16, 2022
Last update posted
Mar 6, 2023

2017 – 2022

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Arizona Arthritis & Rheumatolo /ID# 164446 Phoenix Arizona 85032-9306
AZ Arthritis and Rheumotology Research, PLLC /ID# 165705 Phoenix Arizona 85032-9306
David S. Hallegua MD /ID# 165090 Beverly Hills California 90211
Covina Arthritis Clinic /ID# 165061 Covina California 91722
St. Joseph Health System /ID# 166166 Fullerton California 92835
Global Research Foundation /ID# 165130 Los Angeles California 90041
Rheumatology Center of San Diego /ID# 166167 San Diego California 92128-2549
Colorado Arthritis Associates /ID# 164444 Lakewood Colorado 80228
Bay Area Arthritis and Osteo /ID# 165023 Brandon Florida 33511
LeJenue Research Associates /ID# 165202 Miami Florida 33126
HMD Research LLC /ID# 205172 Orlando Florida 32819
St. Lukes Clinic /ID# 165827 Meridian Idaho 83642
Clinical Investigation Specialists - Skokie /ID# 164385 Skokie Illinois 60076
Henry Ford Health System /ID# 165515 Detroit Michigan 48202
Aa Mrc Llc /Id# 165100 Grand Blanc Michigan 48439
St. Lawrence Health System /ID# 165025 Potsdam New York 13676
DJL Clinical Research, PLLC /ID# 165044 Charlotte North Carolina 28210-8508
Altoona Ctr Clinical Res /ID# 164470 Duncansville Pennsylvania 16635
Clinical Research Ctr Reading /ID# 164876 Wyomissing Pennsylvania 19610
Comprehensive Arthritis Care, a division of Comprehensive Rheumatology Care PLLC /ID# 168107 Hendersonville Tennessee 37075-6213
Diagnostic Group Integrated He /ID# 165195 Beaumont Texas 77701
Arth and Osteo Clin Brazo Valley /ID# 165194 College Station Texas 77845

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03178487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2023 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03178487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →